Nucleic Acid Amplification Testing Market Expected to Reach $9.1 Billion by 2032
According to a new report published by Allied Market Research, titled, “ Nucleic Acid Amplification Testing Market ,” The nucleic acid amplification testing market was valued at $4.8 billion in 2022, and is estimated to reach $9.1 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032. Nucleic acid amplification testing is a molecular diagnostic technique used for detection of various infectious diseases such as HIV, tuberculosis, and cancer, such as cervical cancer. NAAT offers several advantages over the traditional diagnostic techniques, which is one of the major nucleic acid amplification testing market trends. NAAT is sensitive and detects the target molecule in a small sample. This makes it suitable for the detection of infections at an early stage when the pathogen or mutations are at low rate. In addition, NAAT are highly specific in nature which reduces the chances of false results and helps in accurate diagnosis of the condition. Such advantages offered by NAA...